<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02817685</url>
  </required_header>
  <id_info>
    <org_study_id>SYSU2016</org_study_id>
    <nct_id>NCT02817685</nct_id>
  </id_info>
  <brief_title>Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial</brief_title>
  <official_title>Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Third Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Third Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized control prospective study. The aim of this study is to establish
      an all-round and convenient follow-up strategy of Chronic Hepatitis B for early detection and
      diagnosis of Hepatocellular Carcinoma (HCC), by investigating whether different surveillance
      time intervals and surveillance methods are beneficial for chronic hepatitis B and cirrhotic
      patients with different risk of HCC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surveillance of chronic hepatitis B and cirrhotic patients had been demonstrated to increase
      chances of curative treatment for hepatocellular carcinoma. However, the optimal surveillance
      interval for different risk patients is still controversial. The AASLD and EASL-EORTC
      guidelines recommend chronic hepatitis B patients undergoing ultrasound surveillance at a
      time interval of 6 months, but the Japanese HCC guideline recommend the very-high risk
      patients undergoing ultrasound surveillance at a time interval of 3 or 4 months.

      The incidence of HCC is 0.3%-0.8% in the chronic hepatitis B patients and 2%-8% in cirrhotic
      patients, thus recalling a different follow-up strategy for different stage of chronic
      hepatitis B patients. Besides, ultrasound is the admitted surveillance tool for HCC for its
      convenience and cost-effectiveness. However, the sensitivity of ultrasound detecting HCC will
      remarkably decrease because of the influence of ribs, pulmonary and gastrointestinal gas,
      cirrhosis and fatty liver. So it is necessary to incorporate computed tomography (CT) or
      magnetic resonance imaging (MRI) into the follow-up strategy of very high risk patient such
      as patients with cirrhosis or history of HCC.

      The aim of this study is to investigate whether different surveillance time intervals and
      surveillance methods are beneficial for chronic hepatitis B and cirrhotic patients with
      different risk of HCC, ultimately establish an all-round and convenient follow-up strategy of
      Chronic Hepatitis B for early detection and diagnosis of HCC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of Hepatocellular carcinoma</measure>
    <time_frame>3 year</time_frame>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">7660</enrollment>
  <condition>Chronic Hepatitis B</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Chronic Hepatitis B patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Chronic Hepatitis B patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>cirrhotic patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>cirrhotic patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <description>ultrasound-difficult patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <description>ultrasound-difficult patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3 months</intervention_name>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>6 months</intervention_name>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3 month ultrasound(US)+3 month CT/MRI+3 month US+3 month CT/MRI</intervention_name>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic Hepatitis B patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. HBV-Ag positive( ï¼ž6 months)

          2. age among 18 and 80 years

        Exclusion Criteria:

          1. patients with hepatocellular carcinoma

          2. patients were diagnosis hepatocellular carcinoma within 3 months of inclusion;

          3. patients with alcoholic hepatitis or autoimmune hepatitis

          4. patients with severe uncontrolled disease resulting in estimated life expectance less
             than 1 year

          5. coinfection with human immunodeficiency virus(HIV)

          6. cannot undergo contrast-enhanced imaging

          7. refuse attending the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>zhongzhen zz Su, doctor</last_name>
    <role>Study Director</role>
    <affiliation>The department of Ultrasound, the third affiliated hospital of Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>zhongzhen zz Su, doctor</last_name>
    <phone>0086-020-85252010</phone>
    <email>sp9313@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The department of Ultrasound, the third affiliated hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhongzhen zz Su, doctor</last_name>
      <phone>0086-020-85252010</phone>
      <email>sp9313@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2016</study_first_submitted>
  <study_first_submitted_qc>June 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2016</study_first_posted>
  <last_update_submitted>June 27, 2016</last_update_submitted>
  <last_update_submitted_qc>June 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Third Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Rongqin Zheng</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>surveillance</keyword>
  <keyword>hepatocellular carcinoma</keyword>
  <keyword>ultrasound</keyword>
  <keyword>cirrhosis</keyword>
  <keyword>chronic hepatitis B</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
    <mesh_term>Hepatitis B, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

